Your browser is no longer supported. Please, upgrade your browser.
TXMD TherapeuticsMD, Inc. daily Stock Chart
TXMD [NASD]
TherapeuticsMD, Inc.
Index- P/E- EPS (ttm)-0.72 Insider Own6.80% Shs Outstand271.88M Perf Week-9.76%
Market Cap413.90M Forward P/E- EPS next Y-0.30 Insider Trans1.11% Shs Float238.66M Perf Month12.98%
Income-190.20M PEG- EPS next Q-0.14 Inst Own58.90% Short Float35.92% Perf Quarter-25.25%
Sales62.60M P/S6.61 EPS this Y-21.30% Inst Trans3.45% Short Ratio28.25 Perf Half Y51.64%
Book/sh-0.35 P/B- EPS next Y53.10% ROA-76.80% Target Price- Perf Year-48.43%
Cash/sh0.41 P/C3.64 EPS next 5Y21.80% ROE502.80% 52W Range0.85 - 3.81 Perf YTD-38.84%
Dividend- P/FCF- EPS past 5Y-14.60% ROI-79.10% 52W High-61.15% Beta2.11
Dividend %- Quick Ratio3.00 Sales past 5Y27.00% Gross Margin81.70% 52W Low73.51% ATR0.10
Employees348 Current Ratio3.20 Sales Q/Q75.40% Oper. Margin- RSI (14)42.76 Volatility4.26% 6.52%
OptionableYes Debt/Eq- EPS Q/Q16.50% Profit Margin- Rel Volume0.70 Prev Close1.52
ShortableYes LT Debt/Eq- EarningsAug 06 BMO Payout- Avg Volume3.03M Price1.48
Recom2.20 SMA20-7.92% SMA50-2.88% SMA200-5.34% Volume2,126,710 Change-2.63%
Aug-07-20Downgrade Jefferies Hold → Underperform
May-19-20Downgrade JP Morgan Overweight → Neutral
Dec-02-19Initiated Guggenheim Buy
Oct-17-19Initiated H.C. Wainwright Buy $7
Apr-30-19Resumed Noble Capital Markets Outperform $13
Jun-15-18Initiated JP Morgan Overweight $11
Sep-08-17Initiated Morgan Stanley Equal-Weight $6
Jul-11-17Upgrade Oppenheimer Perform → Outperform
May-09-17Downgrade Oppenheimer Outperform → Perform
Nov-22-16Resumed Jefferies Buy $18
Nov-22-16Initiated Oppenheimer Outperform
Nov-07-16Resumed Guggenheim Buy
Apr-04-16Initiated Goldman Buy $10
Dec-08-15Reiterated Stifel Buy $10 → $14
Dec-08-15Reiterated Jefferies Buy $15 → $18
Sep-21-15Reiterated Jefferies Buy $7 → $15
Jun-09-15Initiated Guggenheim Buy
Jul-08-14Initiated FBR Capital Outperform $34
Apr-17-14Reiterated Noble Financial Buy $9 → $13
Jan-28-14Reiterated Noble Financial Buy $7.25 → $9
Oct-22-20 01:16PM  
Oct-09-20 08:00AM  
Oct-07-20 08:43AM  
Oct-06-20 10:03AM  
Oct-02-20 10:17AM  
Sep-25-20 09:02AM  
Sep-21-20 05:01PM  
05:01PM  
Sep-16-20 01:54PM  
Sep-10-20 06:50AM  
Sep-09-20 04:05PM  
Aug-25-20 07:30AM  
Aug-14-20 10:34AM  
Aug-11-20 11:35AM  
Aug-06-20 09:45AM  
06:50AM  
Jul-30-20 12:34PM  
Jul-29-20 06:50AM  
Jul-28-20 12:33PM  
Jul-15-20 06:50AM  
Jun-28-20 09:41AM  
Jun-25-20 04:49PM  
Jun-01-20 06:50AM  
May-27-20 09:47AM  
May-25-20 09:36PM  
May-08-20 06:50AM  
May-07-20 12:00AM  
May-06-20 09:35AM  
07:15AM  
06:50AM  
Apr-29-20 03:00PM  
12:34PM  
06:50AM  
Apr-28-20 06:50AM  
Apr-27-20 12:32PM  
Apr-22-20 06:50AM  
Mar-27-20 08:02AM  
Mar-26-20 04:05PM  
Mar-24-20 07:45AM  
Mar-16-20 06:00AM  
Mar-12-20 11:21AM  
Mar-11-20 06:25PM  
Mar-03-20 12:56PM  
Feb-24-20 08:30AM  
Feb-20-20 08:15AM  
06:57AM  
06:30AM  
Feb-13-20 12:31PM  
06:30AM  
Feb-10-20 06:30AM  
Feb-03-20 06:30AM  
Jan-15-20 10:37AM  
Jan-07-20 06:30AM  
06:30AM  
Jan-06-20 06:55AM  
Dec-30-19 06:55AM  
Dec-16-19 02:02PM  
Nov-26-19 07:30AM  
07:30AM  
Nov-23-19 01:08AM  
Nov-22-19 08:26AM  
Nov-12-19 07:00AM  
Nov-06-19 07:05PM  
04:05PM  
Nov-04-19 10:37AM  
Nov-01-19 04:05PM  
Oct-30-19 05:05PM  
11:19AM  
10:33AM  
Oct-29-19 04:05PM  
Oct-24-19 07:46PM  
07:36AM  
Oct-23-19 04:45PM  
04:41PM  
Oct-11-19 07:00AM  
Oct-10-19 06:45AM  
Oct-08-19 11:55AM  
Oct-07-19 08:34AM  
Sep-26-19 07:00AM  
Sep-24-19 07:00AM  
Sep-18-19 06:30AM  
Sep-04-19 10:05AM  
Aug-21-19 10:06AM  
07:30AM  
Aug-20-19 09:13PM  
08:15PM  
04:53PM  
10:46AM  
Aug-12-19 07:15PM  
Aug-07-19 04:00PM  
Aug-06-19 10:24PM  
06:15PM  
04:05PM  
Jul-25-19 07:00AM  
Jul-22-19 10:31AM  
Jul-16-19 08:21AM  
Jun-14-19 06:08PM  
Jun-12-19 07:25AM  
Jun-10-19 09:39AM  
07:00AM  
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-00THR and TX-0008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. is headquartered in Boca Raton, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Finizio Robert GCEOJun 09Buy1.4446,00066,36018,401,964Jun 10 04:06 PM
Collins Cooper C.DirectorJun 09Buy1.4547,50068,875140,000Jun 10 04:25 PM
Collins Cooper C.DirectorJun 08Buy1.4526,50038,42592,500Jun 10 04:25 PM
Finizio Robert GCEOJun 05Buy1.1530,00034,60018,355,964Jun 08 04:07 PM
Thompson Tommy GDirectorJun 04Buy1.138,7009,831699,600Jun 08 04:12 PM
BISARO PAULDirectorJun 04Buy1.1450,00057,00050,000Jun 08 04:10 PM
Krassan MitchellChief Strategy OfficerFeb 03Option Exercise0.20300,00059,387300,000Feb 05 06:07 PM
Krassan MitchellChief Strategy OfficerFeb 03Sale2.26300,000676,9200Feb 05 06:07 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.